T1	Participants 50 118	hyperglycemic patients with non-ST elevation acute coronary syndrome
T2	Participants 285 349	patients with diabetes receiving standard treatment for diabetes
T3	Participants 691 762	patients with diabetes and A1C of >or=8-10% at randomization (n = 171),
T4	Participants 1709 1776	patients with cardiovascular disease and poorly controlled diabetes